Reicker Pfau represented LungLife AI (LLAI) in its admission to the AIM market of The London Stock Exchange. LungLife was admitted to AIM on July 8, 2021 and raised £17 million at a price at 176p, valuing the company at
Reiker, Pfau, Pyle & McRoy LLP represented Xenon Investment Fund 4, L.P., a software-focused technology private equity firm, in its acquisition of Metricfire.
Reicker, Pfau, Pyle & McRoy LLP represented Pacific Design Technologies, Inc. (“PDT”), a leading provider of advanced, mission-critical thermal management solutions, in its sale to AMETEK, Inc.
Partners Michael Pfau and Russell Terry and associates Lauren Wideman and Nicholas Behrman represented Boulder Scientific Company (“BSC”), a specialty chemical company based in Colorado, in its sale to Quad-C Management, Inc.
Reicker, Pfau, Pyle & McRoy LLP represented SimpleLegal, Inc., a leading provider of law firm management software, in its sale to Onit, Inc, with a team led by partners Michael Pfau and Russell Terry and associates Lauren Wideman and Nicholas Behrman.
